Physician profile
Mark T Langenberg
NPI 1891759767
$3,576.97
in general payments reported to CMS, 2019-2025
41 companies · $499 in 2025
The $499 reported for 2025 was more than what 93% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $500 · 2020: $256 · 2021: $526 · 2022: $812 · 2023: $586 · 2024: $398 · 2025: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,483.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,707.66 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbott Laboratories | $181.05 | 2021-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Lilly USA, LLC | $165.46 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $125.34 | 2021-2025 | Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.51 | 2020-2024 | Ofev |
| Pfizer INC. | $91.30 | 2019-2025 | |
| Astellas Pharma US INC | $90.14 | 2019-2020 | |
| Corcept Therapeutics | $73.29 | 2023-2025 | Korlym |
| Novartis Pharmaceuticals Corporation | $67.64 | 2019 | |
| Sunovion Pharmaceuticals INC. | $66.22 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.69 | 2022-2023 | Xifaxan, Trulance |
| Glaxosmithkline, LLC. | $61.49 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $58.74 | 2021-2022 | |
| Amgen INC. | $46.63 | 2024-2025 | Otezla, Repatha, Repatha |
| Takeda Pharmaceuticals U.S.A., INC. | $43.06 | 2019-2023 | Glassia |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Langenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.